We are international
Donate
TEXT SIZE   


Myeloma Minute
January 28, 2016
01.28.16
January 28, 2016
Share the Minute Facebook Tweet!
Clinical Trials
Donate to the IMF
   

 
This week's question: Can myeloma progress after an autologous stem cell transplant (ASCT)?


Multiple Myeloma Bone Study

New ARROW Clinical Trials: Learn How To Participate

New Selinexor STORM Clinical Trials: Learn How To Participate

New Ixazomib Clinical Trials: Learn How To Participate

Join the conversation about myeloma on the Smart Patients Message Board

Upcoming Events

February 14, 2016
Race Toward a Cure with the IMF in the Skechers LA Marathon

Los Angeles, California

February 26 - February 27, 2016
Patient & Family Seminar

Boca Raton, Florida

March 5, 2016
Regional Community Workshop

Cleveland, Ohio

March 18 - March 19, 2016
Patient & Family Seminar

Seattle, Washington

    

x

Getting Serious -and Silly- About Healthy Eating

We humans are obsessed with and confused by food. In his blog this week, IMF Chairman Dr. Brian Durie considers two recently published books that illustrate both ends of the spectrum. I'll Have What She's Having: My Adventures in Celebrity Dieting is a wry look at the eating habits of the fit and famous (Gwyneth Paltrow, Elizabeth Taylor, Beyoncé). Fat Chance is a more serious examination of the real dangers of sugar and processed foods. To read Dr. Durie’s blog, click HERE.

x

The FDA Approves Kyprolis (carfilzomib) Combination Therapy for Patients with Relapsed or Refractory Multiple Myeloma



 

The FDA announced on January 21, 2016, that Kyprolis® (carfilzomib) has been approved as a supplemental New Drug Application for use in combination with dexamethasone or with lenalidomide plus dex for treatment of multiple myeloma patients with relapsed or refractory disease; these patients must have received one or three lines of previous therapy. Also, the FDA approved Kyprolis® as a single agent for patients in the relapsed or refractory setting who have received one or more lines of therapy. To learn more, click HERE.

x

Boston Celtics Sink Baskets and Donations to the IMF



 

The International Myeloma Foundation is thrilled to announce that this NBA season, the organization’s research and education programs will be the winners in Takeda Oncology’s new campaign “3 Points for Patients.” Each time one of the 17-time champion Boston Celtics sinks a 3-point basket during the regular NBA season, Takeda Oncology will make a donation to the IMF. With the high-scoring Celtics’ track record, that could result in an additional $25,000 to support the IMF.  Learn more from this video with Celtics’ Head Coach Brad Stevens.

x

Register Now for the IMF Patient & Family Seminar in Boca Raton, Florida


 

The IMF Patient & Family Seminar will take place on February 26–27, 2016, at the Boca Raton Marriott in Boca Raton, Florida. The seminar is structured as a two-day format, beginning with a half-day meeting on Friday and a full day "interactive" seminar on Saturday, with world-renowned myeloma experts. Not only will this Patient & Family Seminar offer up-to-date education on myeloma, patients and caregivers may share your experiences and gain strength form other people’s stories. To register, click HERE.

 

 



 


 

 


Join Our Mailing List

 
12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
IMF InfoLine: 800-452-2873 or 818-487-7455
Privacy Policy | Unsubscribe
www.myeloma.org

.

 


 related articles